Table 3:
Bivariate and multivariate analyses of the relationships between baseline characteristics and development of preeclampsia.
|
Characteristics |
Preeclampsia | |||
|---|---|---|---|---|
| Bivariate analyses | Multivariate analyses | |||
| RR (95%CI) | P-value | aRR (95%CI) | P-value | |
| Age in years | ||||
| <30 | 1.00 (ref) | Ref | 1.00 (ref) | Ref |
| 30–34 | 0.78 (0.13–1.62) | 0.701 | 0.84 (0.41–5.10) | 0.111 |
| >34 | 6.19 (2.27–13.01) | 0.023 | 5.62 (2.44–14.79) | 0.005 |
| Parity | ||||
| 0–1 | 1.00 (ref) | Ref | 1.00 (ref) | Ref |
| 2–4 | 2.33 (0.76–7.71) | 0.651 | 1.47 (0.99–9.03) | 0.885 |
| >4 | 4.44 (1.08–10.22) | 0.037 | 5.16 (3.55–8.74) | 0.042 |
| Level of Education | ||||
| Primary | 1.00 (ref) | Ref | NA | |
| Secondary | 1.05 (0.35–4.49) | 0.998 | NA | |
| Tertiary | 3.78 (1.22–15.16) | 0.055 | NA | |
| Homocysteine levels | ||||
| Normal | 1.00 (ref) | Ref | 1.00 (ref) | Ref |
| High | 4.57 (1.52–11.33) | 0.048 | 3.11 (0.77–9.06) | 0.084 |
Abbreviations: RR, crude risk ratio; CI, confidence interval; aRR, adjusted risk ratio.